Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: JNJ stock price vs NTAP: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NTAP's multiple
Needs NTAP P/E.
Implied fair value · at JNJ's multiple
Needs JNJ P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Johnson & Johnson · implied price per share
Bear
$76.44
Base
$92.02
Bull
$112.30
NetApp, Inc. · implied price per share
Bear
$88.82
Base
$102.84
Bull
$121.94
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Pfizer Inc.
JNJ vs PFE
Eli Lilly and Company
JNJ vs LLY
Abbott Laboratories
JNJ vs ABT
Amgen Inc.
JNJ vs AMGN
Pure Storage, Inc.
JNJ vs PSTG
INTERNATIONAL BUSINESS MACHINES CORP
JNJ vs IBM
MICRON TECHNOLOGY INC
JNJ vs MU
Dell Technologies Inc.
JNJ vs DELL
Seagate Technology Holdings plc
JNJ vs STX
Hewlett Packard Enterprise Co
JNJ vs HPE
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe JNJ can sustain its higher margins and conservative leverage profile despite the weak F-Score, then a constructive stance is justified because JNJ offers upside to the implied P/E price while trading below NTAP on P/E and maintaining stronger profitability and balance-sheet quality.
JNJ is priced at $256.35 versus an implied P/E value of $310.06, suggesting 21.0% upside on this framework. However, on relative multiples JNJ trades at a 23.2x P/E versus NTAP at 28.1x and a 6.6x P/S versus NTAP at 5.6x, so the comparison is mixed rather than a clear discount or premium signal.
Supporting Metrics
